Introducing REXULTI® (brexpiprazole): a new PBS-listed antipsychotic for schizophrenia
Por um escritor misterioso
Descrição
October 1st sees the PBS listing of REXULTI, a novel antipsychotic indicated for the treatment of adults with schizophrenia.
ex9902009.jpg
1mg REXULTI TABLET, Schizophrenia, Intas Pharmaceuticals
Rexulti.PDF
Brexpiprazole Updated - Gateway Psychiatric
The Best and Worst Antipsychotics for Mania - Part 3, 2021-11-01
FDA Approves New Schizophrenia, Depression Drug Brexpiprazole - Psychiatry Advisor
PDF] Brexpiprazole (Rexulti): A New Monotherapy for Schizophrenia and Adjunctive Therapy for Major Depressive Disorder.
PDF] Brexpiprazole (Rexulti): A New Monotherapy for Schizophrenia and Adjunctive Therapy for Major Depressive Disorder.
Dichlorophenyl piperazines, including a recently-approved atypical antipsychotic, are potent inhibitors of DHCR7, the last enzyme in cholesterol biosynthesis. - Abstract - Europe PMC
Rexulti 1 Mg, Antipsychotic - 28 Tablets
de
por adulto (o preço varia de acordo com o tamanho do grupo)
